GlassScriptPhysician profile
Sarah Preslar
NPI 1821411265
$1,980.77
in general payments reported to CMS, 2019-2025
20 companies · $659 in 2025
The $659 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.54 · 2022: $255 · 2023: $404 · 2024: $597 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $414.38 | 2023-2025 | Apretude |
| Amgen INC. | $364.83 | 2023-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $283.88 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $179.44 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Gilead Sciences, INC. | $97.95 | 2023-2025 | Epclusa |
| Dynavax Technologies Corporation | $86.84 | 2023-2024 | Heplisav-B |
| Exact Sciences Corporation | $84.60 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $76.23 | 2023-2025 | Aptima, Third Wave |
| Astrazeneca Pharmaceuticals LP | $56.84 | 2022-2023 | Farxiga |
| Pfizer INC. | $53.07 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $49.30 | 2023 | Verquvo, Gardasil 9, Rotateq |
| Abbvie INC. | $49.11 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.78 | 2025 | |
| Dexcom, INC. | $34.95 | 2022 | |
| Glaxosmithkline, LLC. | $32.77 | 2021-2024 | Shingrix, Bexsero |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $21.09 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.12 | 2022 | |
| Medtronic, INC. | $15.53 | 2023 | Inpen Smart Insulin Delivery System |
| Phadia US INC. | $12.04 | 2021 | |
| Organon LLC | $11.02 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Preslar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.